United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2014_register executive 2014-03-25 article Notices D09002ee1c7fa480e D09002ee1c7fa48a6 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States National Institutes of Health originator org United States Government Agency or Subagency This is notice, in accordance with 35 U.S.C. 209 and 37 CFR Part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of a co-exclusive commercial license agreement to practice the inventions embodied in International PCT Application S/N PCT/US03/23317 (HHS Ref. No. E-113- 2003/0-PCT-02) filed July 23, 2003, which published as WO 2004/068104 on August 12, 2004, now expired; U.S. Patent No. 7,709,047 (HHS Ref. No. E-113-2003/0-US-03) issued May 4, 2010; U.S. Patent Application S/N 12/753,566 (HHS Ref. No. E-113-2003/0-US-07) filed April 2, 2010; U.S. Patent No. 7,695,752 (HHS Ref. No. E-113-2003/1-US-01) issued April 13, 2010; U.S. Patent No. 8,460,744 (HHS Ref. No. E-113-2003/1-US-02) issued June 11, 2013; Australian Patent No. 2003256803 (HHS Ref. No. E- 113-2003/0-AU-04) issued January 21, 2010; Australian Patent No. 2009250964 (HHS Ref. No. E-113-2003/0-AU-06) issued March 25, 2013; and Canadian Patent No. 2513646 (HHS Ref. No. E-113-2003/0-CA-05) issued September 17, 2013, all entitled; "Target Activated Microtransfer"; and all continuing applications and foreign counterparts to Ventana Medical Systems, Inc. a company having a place of business in Arizona. The patent rights in these inventions have been assigned to the Government of the United States of America. The prospective co-exclusive license territory may be "worldwide," and the field of use may be limited to the following: 79 FR 16347 https://www.govinfo.gov/app/details/FR-2014-03-25/2014-06413 2014-06413 fr25mr14-91 4140-01-P https://www.govinfo.gov/app/details/FR-2014-03-25/2014-06413 https://www.govinfo.gov/content/pkg/FR-2014-03-25/html/2014-06413.htm https://www.govinfo.gov/content/pkg/FR-2014-03-25/pdf/2014-06413.pdf 1 p. 16347 16347 79 FR 16347 Prospective Grant of Co-Exclusive License: Device and System for Expression Microdissection (xMD); Federal Register Vol. 79, Issue NOTICE 2014-06413 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 2014-04-09 4140-01-P 2014-06413 Notice.

This is notice, in accordance with 35 U.S.C. 209 and 37 CFR Part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of a co-exclusive commercial license agreement to practice the inventions embodied in International PCT Application S/N PCT/US03/23317 (HHS Ref. No. E-113- 2003/0-PCT-02) filed July 23, 2003, which published as WO 2004/068104 on August 12, 2004, now expired; U.S. Patent No. 7,709,047 (HHS Ref. No. E-113-2003/0-US-03) issued May 4, 2010; U.S. Patent Application S/N 12/753,566 (HHS Ref. No. E-113-2003/0-US-07) filed April 2, 2010; U.S. Patent No. 7,695,752 (HHS Ref. No. E-113-2003/1-US-01) issued April 13, 2010; U.S. Patent No. 8,460,744 (HHS Ref. No. E-113-2003/1-US-02) issued June 11, 2013; Australian Patent No. 2003256803 (HHS Ref. No. E- 113-2003/0-AU-04) issued January 21, 2010; Australian Patent No. 2009250964 (HHS Ref. No. E-113-2003/0-AU-06) issued March 25, 2013; and Canadian Patent No. 2513646 (HHS Ref. No. E-113-2003/0-CA-05) issued September 17, 2013, all entitled; "Target Activated Microtransfer"; and all continuing applications and foreign counterparts to Ventana Medical Systems, Inc. a company having a place of business in Arizona. The patent rights in these inventions have been assigned to the Government of the United States of America. The prospective co-exclusive license territory may be "worldwide," and the field of use may be limited to the following:

Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before April 9, 2014 will be considered. Exclusive Licenses: Device and System for Expression Microdissection , changke@mail.nih.gov Vol. 79, no. 57 Office of the Federal Register, National Archives and Records Administration 2014-03-25 continuing daily deposited born digital 488 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2014-03-25 P0b002ee18818283b 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr25mr14 https://www.govinfo.gov/app/details/FR-2014-03-25 https://www.govinfo.gov/content/pkg/FR-2014-03-25/pdf/FR-2014-03-25.pdf https://www.govinfo.gov/content/pkg/FR-2014-03-25/xml/FR-2014-03-25.xml fdlp 16173 16649 DGPO 2014-03-25 2024-06-02 FR-2014-03-25 machine generated eng FR FR-2014-03-25 79 57